EUDAMED Becomes Fully Mandatory from 28 May 2026: What Medical Device & IVD Manufacturers Need to Know
Stef Schutte
02 Dec, 2025
With 30+ years in pharma, Stef has led global Regulatory Affairs at Astellas and served as Head of RA-EMEA at Merck (MSD), advancing development, approvals, and compliance across international markets. Extensive experience in strengthening regulatory operations, accelerating product development pathways, and building high-performing teams.
Other Related Articles
02 Dec, 2025
20 Nov, 2025
11 Nov, 2025
04 Nov, 2025
21 Oct, 2025